Current Neurogene forecasts and price targets in August 2026
Ø Analyst Price Targets
60.18 USD
+69.04 %
Median
61.20 USD
+71.91 %
Max
73.50 USD
Min
46.46 USD
Last Price
35.60 USD
Buy
11
Hold
1
Sell
0
The average target price for Neurogene is 60.18 USD. (+69.04 % above the current price)
The median price target of Neurogene is 61.20 USD.
Stock analysts from many renowned investment banks are closely examining the Neurogene stock. They conclude their professional Neurogene stock analyses with a clear recommendation for the Neurogene stock. The forecasts and price targets of professional analysts can be a good indicator of how a stock will perform in the next quarter.
| Buy | Hold | Sell | Ø Analyst Price Targets | |
|---|---|---|---|---|
| 2026-02-01 | 11 | 1 | 0 | 60.18 USD |
| 2026-01-01 | 11 | 1 | 0 | 60.18 USD |
| 2025-12-01 | 11 | 1 | 0 | 60.18 USD |
| 2025-12-01 | 11 | 1 | 0 | 60.18 USD |
| 2025-11-01 | 11 | 1 | 0 | 60.18 USD |
| 2025-11-01 | 11 | 1 | 0 | 53.81 USD |
Neurogene Stock Forecast 2026: Revenue & Earnings Estimates
Analysts expect the following revenue and earnings for Neurogene in the coming fiscal years:
| Fiscal year | Revenue | Net Income | Earnings per share |
|---|---|---|---|
| 2028e | 67.00 M USD | -73.00 M USD | -4.71 USD |
| 2029e | 137.00 M USD | -28.00 M USD | -1.81 USD |
| 2030e | 406.00 M USD | 94.00 M USD | 6.07 USD |